Get startedLog in
    Picture of ARS Pharmaceuticals logo

    SPRY — ARS Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapSucker Stock
    All News

    Promotion Agreement With Partner And Global Allergy Leader Alk-Abello A/S

    Picture of ARS Pharmaceuticals logoARS Pharmaceuticals
    02/05/2025 14:31
    May 2 (Reuters) - ARS Pharmaceuticals Inc SPRY.O:

ARS PHARMACEUTICALS ANNOUNCES CO-PROMOTION AGREEMENT WITH PARTNER AND GLOBAL ALLERGY LEADER ALK-ABELLÓ A/S TO EXPAND REACH OF NEFFY® (EPINEPHRINE NASAL SPRAY) TO ADDITIONAL U.S. PEDIATRICIANS

ARS PHARMACEUTICALS INC - PHARMA RECEIVED $145 MILLION UPFRONT FROM ALK

Source text: ID:nGNX9l0S2V

Further company coverage: SPRY.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on ARS Pharmaceuticals

    See all news